GovWire

Corporate report: From harm to hope: first annual report 2022 to 2023

Home Office

July 20
12:28 2023

From harm to hope: first annual report 2022 to 2023 (accessible)

From harm to hope: first annual report 2022 to 2023

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The first annual report of the drug strategy sets out the progress from the first year of delivery, one year into the governments 10 year plan.

This report outlines progress on national delivery following the first full year of funding associated with the strategy, including delivery against commitments and goals, the key issues and challenges, including delivery of the recommendations made by the governments Independent Advisor Dame Carol Black in her 2021 Review of Drugs.

There are chapters looking at Combating Drugs Partnerships and the National Outcomes Framework. There is a commitment to support multi-agency delivery through setting out national expectations on local prioritisation, leadership and structures through the development of Combating Drugs Partnerships with Senior Responsible Owners - while the National Outcomes Framework offers a system level view of progress based on our collective goals to deliver meaningful and real change for individuals and communities.

The annual report also looks forward with a focus on action, impact and high-quality system reform.

Published 20 July 2023

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: